Xintela AB (publ)

About:

Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage.

Website: http://www.xintela.se

Top Investors: Almi Invest

Description:

Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors.

Total Funding Amount:

6M SEK

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Lund, Skane Lan, Sweden

Founded Date:

2009-01-01

Contact Email:

info(AT)xintela.se

Founders:

Evy Lundgren-Åkerlund

Number of Employees:

11-50

Last Funding Date:

2013-10-22

IPO Status:

Private

Industries: